Avastin®
Avastin® (bevacizumab) is another anti-VEGF drug commonly used to treat wet AMD, diabetic macular edema, and retinal vein occlusion. Unlike Eylea, Lucentis, and Vabysmo, Avastin was originally developed for cancer treatment but has been widely adopted in ophthalmology because of its effectiveness and affordability in managing retinal disease.
How Avastin Works
Like other anti-VEGF medications, Avastin works by blocking the VEGF protein that triggers abnormal blood vessel growth in the retina. These weak vessels leak fluid and blood, causing swelling that damages vision. By suppressing VEGF activity, Avastin helps reduce swelling, slow disease progression, and preserve sight.
What to Expect During Treatment
Avastin injections are performed in the office using the same sterile technique as other anti-VEGF injections. Your eye will be numbed beforehand, and the injection itself takes only seconds. Most patients feel little discomfort, and temporary irritation afterward is common but mild. Treatment is usually given every 4 to 6 weeks initially, with the possibility of adjusting the schedule as your condition stabilizes.
Benefits of Avastin
Avastin is highly effective in controlling retinal disease and has been widely studied in ophthalmology. One of its advantages is cost—making it an important option for many patients while still providing excellent results. Regular treatment can slow or stop vision loss and, in some cases, lead to vision improvement.
At East Florida Eye Institute, we have extensive experience using Avastin to manage retinal diseases. Our team closely monitors your progress with advanced imaging and follow-up visits, ensuring the treatment is working effectively for your specific needs. We are committed to combining compassionate care with evidence-based medicine so you can feel confident that your vision is in expert hands.